Target intelligence / Profile preview

Staphylococcus epidermidis surface protein C (SesC)

Target
SesC
Molecular classification
Cell surface protein, Adhesin, Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM)
01

Overview

Staphylococcus epidermidis surface protein C (SesC) is a cell wall-anchored protein that functions as an adhesin, playing a pivotal role in the pathogenesis of Staphylococcus epidermidis infections (Shahrooei et al., 2009). It belongs to the Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) family and is instrumental in the initial attachment of bacteria to medical devices and host tissues, as well as the subsequent development of biofilms (UniProt Q5HKP6). SesC is highly conserved and widely expressed among clinical isolates, making it a significant factor in chronic infections associated with indwelling medical devices like catheters and prosthetic joints (Shahrooei et al., 2012). As a surface-exposed protein, it is a primary target for the development of vaccines and therapeutic antibodies aimed at preventing biofilm-mediated infections. Research indicates that blocking SesC can impair the ability of the bacteria to colonize surfaces, thereby increasing their susceptibility to host immune responses and antibiotic treatments. Consequently, SesC represents a strategic target for addressing the growing challenge of antibiotic-resistant staphylococcal infections in healthcare settings.

Other names
SesCSurface protein CS. epidermidis surface protein CCell wall-anchored protein SesC
02

Mechanism of action

Inhibition of bacterial adhesion and biofilm formation by blocking the interaction of SesC with host extracellular matrix components or abiotic surfaces.

03

Biological functions

Cell adhesionBiofilm formationHost-pathogen interactionBacterial colonization
04

Disease associations

InfectionBiofilm-associated infectionProsthetic joint infectionCatheter-related bloodstream infectionNosocomial infection
05

Safety considerations

Potential impact on commensal Staphylococcus epidermidis populationsAntigenic variation leading to immune escapePotential for cross-reactivity with other staphylococcal species
06

Interacting drugs

Anti-SesC monoclonal antibodies

2 more in the full profile.

07

Biomarkers

Anti-SesC antibody titersSesC expression in clinical isolates

Beyond the preview

Go deeper on Staphylococcus epidermidis surface protein C (SesC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus epidermidis surface protein C (SesC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call